Clinical Trial Update: Doxycycline Outcomes in Lupus Erythematosus [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating doxycycline in patients with lupus erythematosus has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Systemic Lupus Erythematosus

Drugs mentioned

• Doxycycline (Doxycycline)

Snippet

Sponsor: Johns Hopkins University | Conditions: Cardiovascular Disease | Phase 4 | Status: WITHDRAWN